Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
In Côte d’Ivoire, two million TB drugs financed by The Global Fund sold in street markets

In Côte d’Ivoire, the Nouvelle Pharmacie de la Santé Publique (NPSP), the facility responsible for receiving, warehousing and distributing medicines, and the Programme National de Lutte contre la Tuberculose (PNLT), a principal recipient, were responsible for a massive diversion of TB drugs financed by The Global Fund.

Published
19 April 2016
From
Global Fund Observer
Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Médecins Sans Frontières (MSF).

Published
24 March 2016
From
Médecins Sans Frontières
Statins cut tuberculosis treatment time in mice

In a study using mice, the Johns Hopkins University School of Medicine infectious disease experts have added to evidence that statin drugs -- known primarily for their cholesterol-lowering effects -- can significantly reduce the time it takes to clear tuberculosis infection.

Published
16 March 2016
From
EurekAlert (press release)
Empirical TB treatment comes up short again

A South African trial has found that a strategy allowing primary care nurses to quickly provide empirical tuberculosis (TB) treatment for newly diagnosed people with advanced HIV disease

Published
26 February 2016
By
Theo Smart
NICE publishes new guideline to better tackle tuberculosis

NICE – the National Institute for Health and Care Excellence of England – published guidance on how to better treat and prevent tuberculosis. England has more TB cases than any other country in Western Europe.

Published
15 January 2016
From
NICE press release
MDR-TB treatment: Six drugs better than five

A regimen containing six drugs was more likely to cure multi-drug resistant tuberculosis (MDR-TB) than a regimen containing five drugs, a nine-country observational study has

Published
13 January 2016
By
Keith Alcorn
Xpert MTB/RIF testing has reduced MDR-TB treatment delays in South Africa

Although the introduction of the Xpert MTB/RIF test for TB and drug-resistant TB has improved the time from clinic presentation to second-line treatment in South Africa since

Published
07 January 2016
By
Lesley Odendal
WHO Sounds Alarm Over Big Indian Supplier Of Tuberculosis Drugs

A major Indian supplier of tuberculosis drugs to developing countries has been severely criticized by the World Health Organization for inadequate manufacturing standards and poor testing procedures. The United Nations agency issued a warning letter to Mumbai-based Svizera Labs, part of Maneesh Pharmaceuticals, stating that the approval and use of its products would be suspended if "critical and major observations are not corrected within a reasonable time frame".

Published
15 September 2015
From
Medical Daily
TAG Pipeline Report

2015 report on the pipeline for new HIV, HCV and TB drugs.

Published
17 July 2015
From
TAG
High-dose rifampicin may shorten time to TB clearance

A combination regimen containing high-dose rifampicin (also known as rifampin) was associated with faster tuberculosis (TB) bacteria culture conversion in people with drug-sensitive TB, but moxifloxacin and

Published
13 April 2015
By
Liz Highleyman
← First12345...14Next →

Filter by country